3.19 USD
▲-0.02+1.27%
盘后 3.20 +1.59%
2026-08-03
市值
$12.17M
市盈率
—
EPS
-12.56
股息率
—
52 周区间
1.92 – 36.25
成交量
33.11K
Beta
1.65
目标价
—
52W 低 1.9252W 高 36.25
价格走势
公司简介
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.